Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis

article OA: closed CC0 ⤵ 72 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Selective cyclo-oxygenase-2 inhibition causes autologous endometrial grafts to regress by reducing vascular endothelial growth factor-mediated angiogenesis and increasing caspase-3-dependent apoptosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo investigate the effects of selective cyclo-oxygenase-2 (COX-2) inhibition on the angiogenesis and proliferation of endometrial grafts.DesignIntravital fluorescence microscopic study.SettingInstitute for Clinical and Experimental Surgery, University of Saarland, Homburg/Saar, Germany.AnimalsSyrian golden hamsters.InterventionsEndometrial fragments were transplanted into dorsal skinfold chambers of Syrian golden hamsters. Animals were treated daily with the selective COX-2-inhibitor NS398; controls received the vehicle dimethyl sulfoxide only.Main outcome measuresAngiogenesis was analyzed for 2 weeks with the use of intravital fluorescence microscopy. Protein expression of vascular endothelial growth factor, proliferating cell nuclear antigen, caspase-3, and activated caspase-3 was measured by Western blot analysis. Histological sections were scanned for local microthrombosis.ResultsCOX-2 inhibition induced a marked regression of endometrial grafts due to inhibition of angiogenesis, as indicated by significantly reduced microvessel density within grafts compared to controls. This effect was associated with a decreased expression of vascular endothelial growth factor. Moreover, COX-2 inhibition suppressed cell proliferation and induced apoptosis-associated caspase-3 expression. Interestingly, microthrombus formation could not be observed.ConclusionsOur study demonstrates that selective COX-2 inhibition induces regression of endometrial grafts by suppression of angiogenesis and stimulation of apoptosis. Accordingly, COX-2 inhibition may represent a novel therapeutic strategy for the treatment of endometriosis.

My notes (saved in your browser only)

MeSH descriptors

Apoptosis Caspase 3 Cyclooxygenase 2 Endometrium Graft Survival Neovascularization, Physiologic Vascular Endothelial Growth Factor A Animals Apoptosis Apoptosis Caspase 3 Cricetinae Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase 2 Inhibitors Down-Regulation Down-Regulation Endometrium Endometrium Endometrium

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (73)

Cited by (50)

Source provenance

crossref
last seen: 2026-08-29T06:28:37.612972+00:00
europepmc
last seen: 2026-10-08T06:18:23.926119+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:12.369988+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK